MedPath

Impact of ondansetron and droperidol about change of corrected QT interval under general anesthesia: a retrospective observational study

Not Applicable
Conditions
patients who undergo general anesthesia
Registration Number
JPRN-UMIN000049592
Lead Sponsor
Shinshu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
360
Inclusion Criteria

Not provided

Exclusion Criteria

1. patient who was administrated other drugs which affect QT interval (drugs which have description about prolongation of QT interval in Japan Pharmaceutical Reference) during from the start of general anesthesia to 30 min after the administration of target drug 2. patient who was administrated both ondansetron and droperidol during from the start of general anesthesia to 30 min after the administration of target drug 3. patient who was administrated target drug more than once 4. patient who was terminated the general anesthesia and the recording of patient monitor before the 30min after the administration of target drug

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
corrected QT interval about every 1 minute from 0 to 10 min and at 30 min after the administration of target drug
Secondary Outcome Measures
NameTimeMethod
1. difference of corrected QT interval between the group of maintenance drug of general anesthesia 2. difference of corrected QT interval between the group of target drug 3. incidence of prolongation of corrected QT interval more than 10 ms 4. number of occurrence of postoperative nausea and vomiting
© Copyright 2025. All Rights Reserved by MedPath